Oncternal Therapeutics Inc (ONCT) — Cash Flow-to-Debt Ratio
Oncternal Therapeutics Inc (ONCT) has a Cash Flow-to-Debt Ratio of -1.08x as of September 2024, meaning its operating cash flow of $-6.95 Million could theoretically repay -1% of its total liabilities ($6.45 Million) in one year. Check how aggressively does Oncternal Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oncternal Therapeutics Inc Cash Flow-to-Debt Ratio (2002–2023)
Historical debt coverage capacity for Oncternal Therapeutics Inc across 22 annual periods. Also explore balance sheet size of Oncternal Therapeutics Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Oncternal Therapeutics Inc (2002–2023)
Year-by-year debt coverage analysis for Oncternal Therapeutics Inc. For market capitalisation and broader financial context, see market value of Oncternal Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | -4.82x | $-32.16 Million | $6.68 Million | ▼ -0.8% |
| 2022 | -4.78x | $-36.70 Million | $7.68 Million | ▲ +1.8% |
| 2021 | -4.87x | $-26.59 Million | $5.46 Million | ▼ -62.9% |
| 2020 | -2.99x | $-17.50 Million | $5.86 Million | ▼ -32.5% |
| 2019 | -2.25x | $-16.75 Million | $7.43 Million | ▲ +70.2% |
| 2018 | -7.55x | $-39.35 Million | $5.21 Million | ▼ -156.7% |
| 2017 | -2.94x | $-23.46 Million | $7.97 Million | ▲ +34.7% |
| 2016 | -4.51x | $-20.78 Million | $4.61 Million | ▼ -578.6% |
| 2015 | -0.66x | $-20.04 Million | $30.17 Million | ▲ +24.2% |
| 2014 | -0.88x | $-28.76 Million | $32.82 Million | ▲ +90.2% |
| 2013 | -8.94x | $-43.97 Million | $4.92 Million | ▼ -142.5% |
| 2012 | -3.68x | $-37.11 Million | $10.07 Million | ▲ +29.7% |
| 2011 | -5.24x | $-33.09 Million | $6.31 Million | ▼ -115.1% |
| 2010 | -2.44x | $-30.53 Million | $12.52 Million | ▼ -252.3% |
| 2009 | -0.69x | $-46.00 Million | $66.47 Million | ▼ -1700.1% |
| 2008 | -0.04x | $-2.92 Million | $76.09 Million | ▲ +91.7% |
| 2007 | -0.47x | $-37.63 Million | $80.81 Million | ▼ -30.9% |
| 2006 | -0.36x | $-11.46 Million | $32.21 Million | ▲ +90.6% |
| 2005 | -3.77x | $-34.82 Million | $9.23 Million | ▼ -120.8% |
| 2004 | -1.71x | $-15.67 Million | $9.17 Million | ▼ -2102.2% |
| 2003 | -0.08x | $-13.00 Million | $167.54 Million | ▲ +52.0% |
| 2002 | -0.16x | $-10.55 Million | $65.34 Million | — |